Global Meningococcal Infections Vaccine Market Research Report 2026(Status and Outlook)
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Meningococcal Infections Vaccine market size was estimated at USD 535.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Meningococcal Infections Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Meningococcal Infections Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Meningococcal Infections Vaccine market.
Global Meningococcal Infections Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Sinopharm
CanSino Biologics
Zhi Fei Biological
Market Segmentation (by Type)
Bivalent
Quadrivalent
Market Segmentation (by Application)
Group A Meningococcal Bacterial Infections
Group C Meningococcal Bacterial Infectio
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Infections Vaccine Market
Overview of the regional outlook of the Meningococcal Infections Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Infections Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Infections Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Meningococcal Infections Vaccine market size was estimated at USD 535.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Meningococcal Infections Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Meningococcal Infections Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Meningococcal Infections Vaccine market.
Global Meningococcal Infections Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer
Sinopharm
CanSino Biologics
Zhi Fei Biological
Market Segmentation (by Type)
Bivalent
Quadrivalent
Market Segmentation (by Application)
Group A Meningococcal Bacterial Infections
Group C Meningococcal Bacterial Infectio
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Infections Vaccine Market
Overview of the regional outlook of the Meningococcal Infections Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Infections Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Infections Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Meningococcal Infections Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Infections Vaccine Segment by Type
1.2.2 Meningococcal Infections Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL INFECTIONS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Infections Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Meningococcal Infections Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL INFECTIONS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Meningococcal Infections Vaccine Product Life Cycle
3.3 Global Meningococcal Infections Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Meningococcal Infections Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningococcal Infections Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Meningococcal Infections Vaccine Market Competitive Situation and Trends
3.8.1 Meningococcal Infections Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Meningococcal Infections Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL INFECTIONS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Infections Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL INFECTIONS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Meningococcal Infections Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Meningococcal Infections Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MENINGOCOCCAL INFECTIONS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Infections Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Meningococcal Infections Vaccine Market Size by Type (2020-2025)
6.4 Global Meningococcal Infections Vaccine Price by Type (2020-2025)
7 MENINGOCOCCAL INFECTIONS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Infections Vaccine Market Sales by Application (2020-2025)
7.3 Global Meningococcal Infections Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2020-2025)
8 MENINGOCOCCAL INFECTIONS VACCINE MARKET SALES BY REGION
8.1 Global Meningococcal Infections Vaccine Sales by Region
8.1.1 Global Meningococcal Infections Vaccine Sales by Region
8.1.2 Global Meningococcal Infections Vaccine Sales Market Share by Region
8.2 Global Meningococcal Infections Vaccine Market Size by Region
8.2.1 Global Meningococcal Infections Vaccine Market Size by Region
8.2.2 Global Meningococcal Infections Vaccine Market Size by Region
8.3 North America
8.3.1 North America Meningococcal Infections Vaccine Sales by Country
8.3.2 North America Meningococcal Infections Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Meningococcal Infections Vaccine Sales by Country
8.4.2 Europe Meningococcal Infections Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Meningococcal Infections Vaccine Sales by Region
8.5.2 Asia Pacific Meningococcal Infections Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Meningococcal Infections Vaccine Sales by Country
8.6.2 South America Meningococcal Infections Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Meningococcal Infections Vaccine Sales by Region
8.7.2 Middle East and Africa Meningococcal Infections Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MENINGOCOCCAL INFECTIONS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Meningococcal Infections Vaccine by Region(2020-2025)
9.2 Global Meningococcal Infections Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Meningococcal Infections Vaccine Production
9.4.1 North America Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Meningococcal Infections Vaccine Production
9.5.1 Europe Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Meningococcal Infections Vaccine Production (2020-2025)
9.6.1 Japan Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Meningococcal Infections Vaccine Production (2020-2025)
9.7.1 China Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.7.2 China Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Meningococcal Infections Vaccine Product Overview
10.1.3 Pfizer Meningococcal Infections Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Sinopharm
10.2.1 Sinopharm Basic Information
10.2.2 Sinopharm Meningococcal Infections Vaccine Product Overview
10.2.3 Sinopharm Meningococcal Infections Vaccine Product Market Performance
10.2.4 Sinopharm Business Overview
10.2.5 Sinopharm SWOT Analysis
10.2.6 Sinopharm Recent Developments
10.3 CanSino Biologics
10.3.1 CanSino Biologics Basic Information
10.3.2 CanSino Biologics Meningococcal Infections Vaccine Product Overview
10.3.3 CanSino Biologics Meningococcal Infections Vaccine Product Market Performance
10.3.4 CanSino Biologics Business Overview
10.3.5 CanSino Biologics SWOT Analysis
10.3.6 CanSino Biologics Recent Developments
10.4 Zhi Fei Biological
10.4.1 Zhi Fei Biological Basic Information
10.4.2 Zhi Fei Biological Meningococcal Infections Vaccine Product Overview
10.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Product Market Performance
10.4.4 Zhi Fei Biological Business Overview
10.4.5 Zhi Fei Biological Recent Developments
11 MENINGOCOCCAL INFECTIONS VACCINE MARKET FORECAST BY REGION
11.1 Global Meningococcal Infections Vaccine Market Size Forecast
11.2 Global Meningococcal Infections Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Infections Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Infections Vaccine Market Size Forecast by Region
11.2.4 South America Meningococcal Infections Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Meningococcal Infections Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Meningococcal Infections Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Meningococcal Infections Vaccine by Type (2026-2035)
12.1.2 Global Meningococcal Infections Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Meningococcal Infections Vaccine by Type (2026-2035)
12.2 Global Meningococcal Infections Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Meningococcal Infections Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Meningococcal Infections Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Meningococcal Infections Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Infections Vaccine Segment by Type
1.2.2 Meningococcal Infections Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL INFECTIONS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Infections Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Meningococcal Infections Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL INFECTIONS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Meningococcal Infections Vaccine Product Life Cycle
3.3 Global Meningococcal Infections Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Meningococcal Infections Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningococcal Infections Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Meningococcal Infections Vaccine Market Competitive Situation and Trends
3.8.1 Meningococcal Infections Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Meningococcal Infections Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL INFECTIONS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Infections Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL INFECTIONS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Meningococcal Infections Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Meningococcal Infections Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MENINGOCOCCAL INFECTIONS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Infections Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Meningococcal Infections Vaccine Market Size by Type (2020-2025)
6.4 Global Meningococcal Infections Vaccine Price by Type (2020-2025)
7 MENINGOCOCCAL INFECTIONS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Infections Vaccine Market Sales by Application (2020-2025)
7.3 Global Meningococcal Infections Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2020-2025)
8 MENINGOCOCCAL INFECTIONS VACCINE MARKET SALES BY REGION
8.1 Global Meningococcal Infections Vaccine Sales by Region
8.1.1 Global Meningococcal Infections Vaccine Sales by Region
8.1.2 Global Meningococcal Infections Vaccine Sales Market Share by Region
8.2 Global Meningococcal Infections Vaccine Market Size by Region
8.2.1 Global Meningococcal Infections Vaccine Market Size by Region
8.2.2 Global Meningococcal Infections Vaccine Market Size by Region
8.3 North America
8.3.1 North America Meningococcal Infections Vaccine Sales by Country
8.3.2 North America Meningococcal Infections Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Meningococcal Infections Vaccine Sales by Country
8.4.2 Europe Meningococcal Infections Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Meningococcal Infections Vaccine Sales by Region
8.5.2 Asia Pacific Meningococcal Infections Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Meningococcal Infections Vaccine Sales by Country
8.6.2 South America Meningococcal Infections Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Meningococcal Infections Vaccine Sales by Region
8.7.2 Middle East and Africa Meningococcal Infections Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MENINGOCOCCAL INFECTIONS VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Meningococcal Infections Vaccine by Region(2020-2025)
9.2 Global Meningococcal Infections Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Meningococcal Infections Vaccine Production
9.4.1 North America Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Meningococcal Infections Vaccine Production
9.5.1 Europe Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Meningococcal Infections Vaccine Production (2020-2025)
9.6.1 Japan Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Meningococcal Infections Vaccine Production (2020-2025)
9.7.1 China Meningococcal Infections Vaccine Production Growth Rate (2020-2025)
9.7.2 China Meningococcal Infections Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Basic Information
10.1.2 Pfizer Meningococcal Infections Vaccine Product Overview
10.1.3 Pfizer Meningococcal Infections Vaccine Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Sinopharm
10.2.1 Sinopharm Basic Information
10.2.2 Sinopharm Meningococcal Infections Vaccine Product Overview
10.2.3 Sinopharm Meningococcal Infections Vaccine Product Market Performance
10.2.4 Sinopharm Business Overview
10.2.5 Sinopharm SWOT Analysis
10.2.6 Sinopharm Recent Developments
10.3 CanSino Biologics
10.3.1 CanSino Biologics Basic Information
10.3.2 CanSino Biologics Meningococcal Infections Vaccine Product Overview
10.3.3 CanSino Biologics Meningococcal Infections Vaccine Product Market Performance
10.3.4 CanSino Biologics Business Overview
10.3.5 CanSino Biologics SWOT Analysis
10.3.6 CanSino Biologics Recent Developments
10.4 Zhi Fei Biological
10.4.1 Zhi Fei Biological Basic Information
10.4.2 Zhi Fei Biological Meningococcal Infections Vaccine Product Overview
10.4.3 Zhi Fei Biological Meningococcal Infections Vaccine Product Market Performance
10.4.4 Zhi Fei Biological Business Overview
10.4.5 Zhi Fei Biological Recent Developments
11 MENINGOCOCCAL INFECTIONS VACCINE MARKET FORECAST BY REGION
11.1 Global Meningococcal Infections Vaccine Market Size Forecast
11.2 Global Meningococcal Infections Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Infections Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Infections Vaccine Market Size Forecast by Region
11.2.4 South America Meningococcal Infections Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Meningococcal Infections Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Meningococcal Infections Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Meningococcal Infections Vaccine by Type (2026-2035)
12.1.2 Global Meningococcal Infections Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Meningococcal Infections Vaccine by Type (2026-2035)
12.2 Global Meningococcal Infections Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Meningococcal Infections Vaccine Sales (K Units) Forecast by Application
12.2.2 Global Meningococcal Infections Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Meningococcal Infections Vaccine Market Size by Type (M USD)
Table 4. Global Meningococcal Infections Vaccine Market Size by Application
Table 5. Meningococcal Infections Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Meningococcal Infections Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Infections Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Meningococcal Infections Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Meningococcal Infections Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2025)
Table 11. Global Market Meningococcal Infections Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Meningococcal Infections Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Infections Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Meningococcal Infections Vaccine Sales by Type (K Units)
Table 27. Global Meningococcal Infections Vaccine Market Size by Type (M USD)
Table 28. Global Meningococcal Infections Vaccine Sales (K Units) by Type (2020-2025)
Table 29. Global Meningococcal Infections Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Meningococcal Infections Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Meningococcal Infections Vaccine Market Share by Type (2020-2025)
Table 32. Global Meningococcal Infections Vaccine Price (USD/Unit) by Type (2020-2025)
Table 33. Global Meningococcal Infections Vaccine Sales (K Units) by Application
Table 34. Global Meningococcal Infections Vaccine Market Size by Application
Table 35. Global Meningococcal Infections Vaccine Sales by Application (2020-2025) & (K Units)
Table 36. Global Meningococcal Infections Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Meningococcal Infections Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Meningococcal Infections Vaccine Market Share by Application (2020-2025)
Table 39. Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Meningococcal Infections Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. Global Meningococcal Infections Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025)
Table 44. North America Meningococcal Infections Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. North America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Meningococcal Infections Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Meningococcal Infections Vaccine Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Meningococcal Infections Vaccine Sales by Country (2020-2025) & (K Units)
Table 51. South America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Meningococcal Infections Vaccine Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Meningococcal Infections Vaccine Production (K Units) by Region(2020-2025)
Table 55. Global Meningococcal Infections Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Meningococcal Infections Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Meningococcal Infections Vaccine Product Overview
Table 64. Pfizer Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Sinopharm Basic Information
Table 69. Sinopharm Meningococcal Infections Vaccine Product Overview
Table 70. Sinopharm Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Sinopharm Business Overview
Table 72. Sinopharm SWOT Analysis
Table 73. Sinopharm Recent Developments
Table 74. CanSino Biologics Basic Information
Table 75. CanSino Biologics Meningococcal Infections Vaccine Product Overview
Table 76. CanSino Biologics Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. CanSino Biologics Business Overview
Table 78. CanSino Biologics SWOT Analysis
Table 79. CanSino Biologics Recent Developments
Table 80. Zhi Fei Biological Basic Information
Table 81. Zhi Fei Biological Meningococcal Infections Vaccine Product Overview
Table 82. Zhi Fei Biological Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Zhi Fei Biological Business Overview
Table 84. Zhi Fei Biological Recent Developments
Table 85. Global Meningococcal Infections Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 86. Global Meningococcal Infections Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 87. North America Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 88. North America Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 89. Europe Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 90. Europe Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Asia Pacific Meningococcal Infections Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 92. Asia Pacific Meningococcal Infections Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 94. South America Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Middle East and Africa Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 96. Middle East and Africa Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Global Meningococcal Infections Vaccine Sales Forecast by Type (2026-2035) & (K Units)
Table 98. Global Meningococcal Infections Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 99. Global Meningococcal Infections Vaccine Price Forecast by Type (2026-2035) & (USD/Unit)
Table 100. Global Meningococcal Infections Vaccine Sales (K Units) Forecast by Application (2026-2035)
Table 101. Global Meningococcal Infections Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Meningococcal Infections Vaccine Market Size by Type (M USD)
Table 4. Global Meningococcal Infections Vaccine Market Size by Application
Table 5. Meningococcal Infections Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Meningococcal Infections Vaccine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Infections Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Meningococcal Infections Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Meningococcal Infections Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Infections Vaccine as of 2025)
Table 11. Global Market Meningococcal Infections Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Meningococcal Infections Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Infections Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Meningococcal Infections Vaccine Sales by Type (K Units)
Table 27. Global Meningococcal Infections Vaccine Market Size by Type (M USD)
Table 28. Global Meningococcal Infections Vaccine Sales (K Units) by Type (2020-2025)
Table 29. Global Meningococcal Infections Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Meningococcal Infections Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Meningococcal Infections Vaccine Market Share by Type (2020-2025)
Table 32. Global Meningococcal Infections Vaccine Price (USD/Unit) by Type (2020-2025)
Table 33. Global Meningococcal Infections Vaccine Sales (K Units) by Application
Table 34. Global Meningococcal Infections Vaccine Market Size by Application
Table 35. Global Meningococcal Infections Vaccine Sales by Application (2020-2025) & (K Units)
Table 36. Global Meningococcal Infections Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Meningococcal Infections Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Meningococcal Infections Vaccine Market Share by Application (2020-2025)
Table 39. Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Meningococcal Infections Vaccine Sales by Region (2020-2025) & (K Units)
Table 41. Global Meningococcal Infections Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025)
Table 44. North America Meningococcal Infections Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. North America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Meningococcal Infections Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Europe Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Meningococcal Infections Vaccine Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Meningococcal Infections Vaccine Sales by Country (2020-2025) & (K Units)
Table 51. South America Meningococcal Infections Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Meningococcal Infections Vaccine Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Meningococcal Infections Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Meningococcal Infections Vaccine Production (K Units) by Region(2020-2025)
Table 55. Global Meningococcal Infections Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Meningococcal Infections Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Meningococcal Infections Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Pfizer Basic Information
Table 63. Pfizer Meningococcal Infections Vaccine Product Overview
Table 64. Pfizer Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer Business Overview
Table 66. Pfizer SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Sinopharm Basic Information
Table 69. Sinopharm Meningococcal Infections Vaccine Product Overview
Table 70. Sinopharm Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Sinopharm Business Overview
Table 72. Sinopharm SWOT Analysis
Table 73. Sinopharm Recent Developments
Table 74. CanSino Biologics Basic Information
Table 75. CanSino Biologics Meningococcal Infections Vaccine Product Overview
Table 76. CanSino Biologics Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. CanSino Biologics Business Overview
Table 78. CanSino Biologics SWOT Analysis
Table 79. CanSino Biologics Recent Developments
Table 80. Zhi Fei Biological Basic Information
Table 81. Zhi Fei Biological Meningococcal Infections Vaccine Product Overview
Table 82. Zhi Fei Biological Meningococcal Infections Vaccine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Zhi Fei Biological Business Overview
Table 84. Zhi Fei Biological Recent Developments
Table 85. Global Meningococcal Infections Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 86. Global Meningococcal Infections Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 87. North America Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 88. North America Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 89. Europe Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 90. Europe Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Asia Pacific Meningococcal Infections Vaccine Sales Forecast by Region (2026-2035) & (K Units)
Table 92. Asia Pacific Meningococcal Infections Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (K Units)
Table 94. South America Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Middle East and Africa Meningococcal Infections Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 96. Middle East and Africa Meningococcal Infections Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Global Meningococcal Infections Vaccine Sales Forecast by Type (2026-2035) & (K Units)
Table 98. Global Meningococcal Infections Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 99. Global Meningococcal Infections Vaccine Price Forecast by Type (2026-2035) & (USD/Unit)
Table 100. Global Meningococcal Infections Vaccine Sales (K Units) Forecast by Application (2026-2035)
Table 101. Global Meningococcal Infections Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Meningococcal Infections Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Infections Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Meningococcal Infections Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Meningococcal Infections Vaccine Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Infections Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningococcal Infections Vaccine Product Life Cycle
Figure 13. Meningococcal Infections Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Meningococcal Infections Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Meningococcal Infections Vaccine Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningococcal Infections Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Meningococcal Infections Vaccine
Figure 19. Global Meningococcal Infections Vaccine Market PEST Analysis
Figure 20. Global Meningococcal Infections Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Meningococcal Infections Vaccine Market Share by Type
Figure 27. Sales Market Share of Meningococcal Infections Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Meningococcal Infections Vaccine by Type in 2025
Figure 29. Market Share of Meningococcal Infections Vaccine by Type (2020-2025)
Figure 30. Market Share of Meningococcal Infections Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Meningococcal Infections Vaccine Market Share by Application
Figure 33. Global Meningococcal Infections Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Meningococcal Infections Vaccine Sales Market Share by Application in 2025
Figure 35. Global Meningococcal Infections Vaccine Market Share by Application (2020-2025)
Figure 36. Global Meningococcal Infections Vaccine Market Share by Application in 2025
Figure 37. Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Meningococcal Infections Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025)
Figure 40. North America Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Meningococcal Infections Vaccine Sales Market Share by Country in 2024
Figure 43. North America Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Meningococcal Infections Vaccine Market Size by Country in 2024
Figure 45. U.S. Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Meningococcal Infections Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Meningococcal Infections Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Meningococcal Infections Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Meningococcal Infections Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Meningococcal Infections Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Meningococcal Infections Vaccine Market Size by Country in 2024
Figure 55. Germany Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Meningococcal Infections Vaccine Market Size by Region in 2024
Figure 68. China Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Meningococcal Infections Vaccine Sales Market Share by Country in 2024
Figure 80. South America Meningococcal Infections Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Meningococcal Infections Vaccine Market Size by Country in 2024
Figure 82. Brazil Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Meningococcal Infections Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Meningococcal Infections Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Meningococcal Infections Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Meningococcal Infections Vaccine Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Meningococcal Infections Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Meningococcal Infections Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Meningococcal Infections Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Meningococcal Infections Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Meningococcal Infections Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Meningococcal Infections Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Infections Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Meningococcal Infections Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Meningococcal Infections Vaccine Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Infections Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningococcal Infections Vaccine Product Life Cycle
Figure 13. Meningococcal Infections Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Meningococcal Infections Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Meningococcal Infections Vaccine Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningococcal Infections Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Meningococcal Infections Vaccine
Figure 19. Global Meningococcal Infections Vaccine Market PEST Analysis
Figure 20. Global Meningococcal Infections Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Meningococcal Infections Vaccine Market Share by Type
Figure 27. Sales Market Share of Meningococcal Infections Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Meningococcal Infections Vaccine by Type in 2025
Figure 29. Market Share of Meningococcal Infections Vaccine by Type (2020-2025)
Figure 30. Market Share of Meningococcal Infections Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Meningococcal Infections Vaccine Market Share by Application
Figure 33. Global Meningococcal Infections Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Meningococcal Infections Vaccine Sales Market Share by Application in 2025
Figure 35. Global Meningococcal Infections Vaccine Market Share by Application (2020-2025)
Figure 36. Global Meningococcal Infections Vaccine Market Share by Application in 2025
Figure 37. Global Meningococcal Infections Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Meningococcal Infections Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Meningococcal Infections Vaccine Market Size by Region (2020-2025)
Figure 40. North America Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Meningococcal Infections Vaccine Sales Market Share by Country in 2024
Figure 43. North America Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Meningococcal Infections Vaccine Market Size by Country in 2024
Figure 45. U.S. Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Meningococcal Infections Vaccine Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Meningococcal Infections Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Meningococcal Infections Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Meningococcal Infections Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Meningococcal Infections Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Meningococcal Infections Vaccine Market Size by Country in 2024
Figure 55. Germany Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Meningococcal Infections Vaccine Market Size by Region in 2024
Figure 68. China Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 79. South America Meningococcal Infections Vaccine Sales Market Share by Country in 2024
Figure 80. South America Meningococcal Infections Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Meningococcal Infections Vaccine Market Size by Country in 2024
Figure 82. Brazil Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Meningococcal Infections Vaccine Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Meningococcal Infections Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Meningococcal Infections Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Meningococcal Infections Vaccine Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Meningococcal Infections Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Meningococcal Infections Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 106. China Meningococcal Infections Vaccine Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Meningococcal Infections Vaccine Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Meningococcal Infections Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Meningococcal Infections Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Meningococcal Infections Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Meningococcal Infections Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Meningococcal Infections Vaccine Market Share Forecast by Application (2026-2035)
